Summit Therapeutics Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 157.7M | 132.6M | 147.3M | 131.1M | 151.6M | 39.7M | 41.0M | 28.2M |
| Operating Expenses | 220.5M | 195.2M | 224.9M | 234.2M | 414.1M | 51.7M | 52.4M | 43.7M |
| Operating Income | -220.5M | -195.2M | -224.9M | -234.2M | -414.1M | -51.7M | -52.4M | -43.7M |
| Other Income / Gains | 4.8M | 5.8M | 5.8M | 2.4M | 2.0M | 3.0M | 3.5M | 1.6M |
| Net Income | -215.7M | -189.4M | -219.2M | -231.8M | -412.2M | -48.7M | -48.9M | -42.1M |
| EPS (Diluted) | -0.28 | -0.24 | -0.29 | -0.31 | -0.56 | -0.066 | -0.066 | -0.058 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 62.8M | 62.6M | 77.6M | 103.1M | 262.6M | 12.1M | 11.5M | 15.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 62.8M | 62.6M | 77.6M | 103.1M | 262.6M | 12.1M | 11.5M | 15.3M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -164K | 197K |
| Cost And Expenses | 220.5M | 195.2M | 224.9M | 234.2M | 414.1M | 51.7M | 52.4M | 43.7M |
| Interest Income | 0 | 5.8M | 5.9M | 2.8M | 3.0M | 0 | 13.5M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 9K | 2.5M |
| Depreciation And Amortization | 0 | 44K | 42K | 42K | 27K | 19K | 18K | 15K |
| Ebitda | -215.7M | -189.4M | -219.1M | -231.8M | -414.1M | -48.7M | -48.9M | -39.6M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -215.7M | -189.4M | -219.1M | -231.8M | -412.2M | -48.7M | -48.9M | -42.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.28 | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.072 | -0.06 |
| Weighted Average Shs Out | 778.2M | 775.5M | 766.4M | 743.4M | 742.6M | 699.0M | 683.2M | 703.2M |
| Weighted Average Shs Out Dil | 778.2M | 775.5M | 766.4M | 743.4M | 742.6M | 738.1M | 737.5M | 726.7M |